e-learning
resources
Madrid 2019
Sunday, 29.09.2019
NELSON: the Trafalgar of lung cancer screening?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
(Not) screening smokers: a patient’s view
J. Rawlinson (Tipton, United Kingdom)
Source:
International Congress 2019 – NELSON: the Trafalgar of lung cancer screening?
Session:
NELSON: the Trafalgar of lung cancer screening?
Session type:
Symposium
Number:
1555
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Rawlinson (Tipton, United Kingdom). (Not) screening smokers: a patient’s view. International Congress 2019 – NELSON: the Trafalgar of lung cancer screening?
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Smoking assessment & treatment in hospital: Are we providing ‘right care‘ and/or missing cannabis-smoking?
Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment
Year: 2011
A follow-up study (MARKO) supports the need to change the diagnostic criteria for COPD
Source: International Congress 2016 – New approaches and finding in smoking cessation
Year: 2016
Current screening programs for lung cancer – Are inclusion criteria too rigorous to identify asymptomatic patients?
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011
Late Breaking Abstract: The ERS recommendations on smoking cessation: Can they be used in clinical practice? The
ICEBERG
project (
I
mplementation of smoking
CE
ssation in respiratory
P
atients according to the
ER
S
G
uidelines)
Source: Annual Congress 2010 - Education for smoking control
Year: 2010
E cigarettes and children: should we be concerned?
Source: International Congress 2018 – State of the art session: Paediatric respiratory diseases
Year: 2018
Screening for lung cancer: who should (not) be enrolled?
Source: International Congress 2019 – NELSON: the Trafalgar of lung cancer screening?
Year: 2019
smoking cessation program: where do our patients come from?
Source: International Congress 2018 – Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations
Year: 2018
Identifying a ‘frequent exacerbator‘ phenotype in a cohort of COPD patients (EXACO study)
Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease
Year: 2012
Finding the missing millions with COPD – Does it work?
Source: Annual Congress 2012 - Going with the flow: assessment and evaluation of airway function and its role in patient management
Year: 2012
Respirologists‘ perception versus patient reality: A Canadian perspective on COPD
Source: Annual Congress 2011 - Integrated care and telehealth in primary care
Year: 2011
Who win? Spirometry versus symptoms for predicting the longitudinal outcomes in COPD patients – 10 years observation
Source: Annual Congress 2011 - Clinical parameters in airway diseases
Year: 2011
Preference, satisfaction and critical errors with Genuair® and HandiHaler® in patients with COPD
Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Year: 2012
Documentation & accuracy of smoking status – An educational need?
Source: Annual Congress 2011 - Smoking cessation science and smoking-related disorders
Year: 2011
Prevalence of asthmatic smokers: Turkish experience (PASTE study)
Source: Annual Congress 2008 - Tobacco smoking by population subgroups
Year: 2008
Doctors (drs) knowledge of diagnosing, investigating & managing pulmonary embolus (PE) in pregnancy?
Source: Annual Congress 2009 - Pulmonary embolism
Year: 2009
Asthma control test – Suitable for children from 4 to 11 years?
Source: Annual Congress 2010 - Quality of life, asthma control and monitoring childhood asthma
Year: 2010
Late Breaking Abstract: Inhalation technique errors and education effects in the group of patients using Aerolizer® – The real life study
Source: Annual Congress 2010 - Medical education: methodology
Year: 2010
Identifying the at risk smokers: who goes on to get COPD?
Source: Eur Respir J, 54 (4) 1901613; 10.1183/13993003.01613-2019
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept